Jade Biosciences, Inc.
JBIO
$8.03
$0.131.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -32.13M | -38.17M | |||
| Total Depreciation and Amortization | -3.00K | 8.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 10.15M | 17.82M | |||
| Change in Net Operating Assets | 1.83M | 1.58M | |||
| Cash from Operations | -20.16M | -18.76M | |||
| Capital Expenditure | -136.00K | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -136.00K | -- | |||
| Total Debt Issued | 205.00M | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -13.69M | -700.00K | |||
| Cash from Financing | 191.31M | -700.00K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 171.01M | -19.46M | |||